Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Alector stock | $23.61

Learn how to easily invest in Alector stock.

Alector Inc is a biotechnology business based in the US. Alector shares (ALEC) are listed on the NASDAQ and all prices are listed in US Dollars. Alector employs 184 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Alector

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – ALEC – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Alector stock price (NASDAQ: ALEC)

Use our graph to track the performance of ALEC stocks over time.

Alector shares at a glance

Information last updated 2021-10-16.
Latest market close$23.61
52-week range$9.12 - $39.74
50-day moving average $24.57
200-day moving average $23.43
Wall St. target price$44.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-2.68

Buy Alector shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
$20 per year
Financial advice powered by relationships, not commissions.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Alector stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Alector price performance over time

Historical closes compared with the close of $23.61 from 2021-10-22

1 week (2021-10-13) -2.52%
1 month (2021-09-20) -8.38%
3 months (2021-07-23) -27.95%
6 months (2021-04-23) 25.85%
1 year (2020-10-23) 148.79%
2 years (2019-10-23) 46.46%
3 years (2018-10-20) N/A
5 years (2016-10-20) N/A

Alector financials

Revenue TTM $21.4 million
Gross profit TTM $-135,771,000
Return on assets TTM -27.63%
Return on equity TTM -78.62%
Profit margin 0%
Book value $2.31
Market capitalisation $1.9 billion

TTM: trailing 12 months

Shorting Alector shares

There are currently 7.5 million Alector shares held short by investors – that's known as Alector's "short interest". This figure is 10.7% up from 6.8 million last month.

There are a few different ways that this level of interest in shorting Alector shares can be evaluated.

Alector's "short interest ratio" (SIR)

Alector's "short interest ratio" (SIR) is the quantity of Alector shares currently shorted divided by the average quantity of Alector shares traded daily (recently around 857868.94977169). Alector's SIR currently stands at 8.76. In other words for every 100,000 Alector shares traded daily on the market, roughly 8760 shares are currently held short.

However Alector's short interest can also be evaluated against the total number of Alector shares, or, against the total number of tradable Alector shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Alector's short interest could be expressed as 0.09% of the outstanding shares (for every 100,000 Alector shares in existence, roughly 90 shares are currently held short) or 0.1412% of the tradable shares (for every 100,000 tradable Alector shares, roughly 141 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Alector.

Find out more about how you can short Alector stock.

Alector share dividends

We're not expecting Alector to pay a dividend over the next 12 months.

Alector share price volatility

Over the last 12 months, Alector's shares have ranged in value from as little as $9.12 up to $39.74. A popular way to gauge a stock's volatility is its "beta".

ALEC.US volatility(beta: 1.16)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Alector's is 1.1566. This would suggest that Alector's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Alector overview

Alector, Inc. , a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis diseases; and AL101 that is in Phase I clinical trial for the treatment of neurodegenerative diseases, including Alzheimer's and Parkinson's diseases. The company also offers AL002, a product candidate that is in Phase II clinical trial for the treatment of Alzheimer's disease; and AL003, which is in Phase Ib clinical trial for the treatment of Alzheimer's disease. In addition, its products in development stage include AL044 that targets MS4A4A, a risk gene for Alzheimer's disease; and 8 candidates in immuno-neurology/immuno-oncology field comprise ADP012, ADP016, ADP017, ADP023, ADP026, ADP122, ADP009, and ADP022. Alector, Inc. has a collaboration agreement with Adimab, LLC for the research and development of antibodies; and a strategic collaboration agreement with GlaxoSmithKline plc for the development and commercialization of monoclonal antibodies, such as AL001 and AL101 to treat neurodegenerative diseases.

Frequently asked questions

What percentage of Alector is owned by insiders or institutions?
Currently 13.036% of Alector shares are held by insiders and 78.887% by institutions.
How many people work for Alector?
Latest data suggests 184 work at Alector.
When does the fiscal year end for Alector?
Alector's fiscal year ends in December.
Where is Alector based?
Alector's address is: 131 Oyster Point Boulevard, South San Francisco, CA, United States, 94080
What is Alector's ISIN number?
Alector's international securities identification number is: US0144421072
What is Alector's CUSIP number?
Alector's Committee on Uniform Securities Identification Procedures number is: 014442107

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site